- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
High total cholesterol and LDL-C levels during midlife reduce risk of atrial fibrillation
A new study published in PLOS Medicine suggests that midlife high total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) were linked to a reduced incidence of atrial fibrillation (AF), although this link persisted only for the first five years following lipid testing.
It is still debatable whether cholesterol levels play a part in the onset of atrial fibrillation. Additionally, the existence and magnitude of an association between apolipoproteins and the risk of AF are seldom investigated. In this investigation, Mozhu Ding and colleagues sought to better understand the relationship between midlife blood lipid levels and the likelihood of developing new-onset AF.
65,136 people from the Swedish Apolipoprotein-Related Mortality Risk (AMORIS) cohort, aged 45 to 60, who had no overt cardiovascular illnesses (CVDs), were included in this population-based investigation. Individuals were monitored for incident AF until December 31, 2019, and lipid measurements were done from 1985 to 1996. (i.e., study outcome).
The key findings of this study were:
1. 13,871 (21.3%) incident AF cases occurred over a mean follow-up of 24.2 years.
2. During the first five years of follow-up but not later, higher levels of total cholesterol and low-density lipoprotein cholesterol were statistically significantly related with a decreased risk of AF.
3. Over the course of the full follow-up, lower levels of high-density lipoprotein cholesterol (HDL-C), apolipoprotein A-I (ApoA-I), and greater triglycerides (TG)/HDL-C ratio were statistically substantially linked to a higher risk of AF.
4. The ratio of apolipoprotein B (ApoB) to apolipoprotein A-I did not predict the incidence of AF.
5. Both those who experienced incident heart failure (HF) or coronary heart disease (CHD) and individuals who did not experience the same relationships.
In conclusion, up to 5 years following blood measurement, a lower risk of AF was shown in conjunction with high TC and LDL-C levels in this sizable population-based investigation. On the other hand, during a period of three decades of follow-up, low HDL-C, low ApoA-I, and a high TG/HDL-C ratio were persistently linked to a greater risk of AF. A high ApoB/ApoA-I ratio, which indicates a poor atherogenic and anti-atherogenic balance, is not linked to an increased risk of AF.
Reference:
Ding, M., Wennberg, A., Gigante, B., Walldius, G., Hammar, N., & Modig, K. (2022). Lipid levels in midlife and risk of atrial fibrillation over 3 decades-Experience from the Swedish AMORIS cohort: A cohort study. PLoS Medicine, 19(8), e1004044. https://doi.org/10.1371/journal.pmed.1004044
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751